Bristol-Myers Squibb Company
DE ˙ XTRA ˙ US1101221083
47,43 € ↓ -0,01 (-0,01%)
2026-06-04
DEL PRIS
SecurityDE:BRM / Bristol-Myers Squibb Company
InstitutionNorden Group Llc
Latest Disclosed Ownership200,824 shares
Latest Disclosed Value $ 12,179,978
Norden Group Llc reports 13.51% increase in ownership of BRM / Bristol-Myers Squibb Company

On April 15, 2026 - Norden Group Llc filed a 13F-HR form disclosing ownership of 200,824 shares of Bristol-Myers Squibb Company (DE:BRM) valued at $10,527,194 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 13, 2026 disclosing 176,915 shares of Bristol-Myers Squibb Company. This represents a change in shares of 13.51% during the quarter. The current value of the position is $9,525,082 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-15 2026-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 200,824 23,909 13.51 12,180 27.64 1.1702
2026-01-13 2025-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 176,915 157,604 816.14 9,543 996.78 0.9343
2025-10-15 2025-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 19,311 -375 -1.90 871 -4.50 0.0885
2025-07-15 2025-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 19,686 -73,134 -78.79 911 -83.91 0.0989
2025-05-07 2025-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 92,820 744 0.81 5,661 8.72 0.6515
2025-02-05 2024-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 92,076 70,423 325.23 5,208 364.91 0.5890
2024-10-17 2024-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 21,653 11,158 106.32 1,120 157.47 0.1322
2024-08-06 2024-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 10,495 -3,351 -24.20 436 -42.00 0.0881
2024-04-30 2024-03-31 13F/A-1 BRISTOL-MYERS SQUIBB COM 110122108 13,846 3,213 30.22 751 37.61 0.1525
2024-04-19 2024-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 236,606 225,973 12,831 0.1427
2024-02-05 2023-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 10,633 773 7.84 546 -4.72 0.0939
2023-11-06 2023-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 9,860 9,860 572 0.1883
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.